Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 30.70%-1.33M | 65.36%-186.53K | 42.33%-261.76K | 74.41%-194.39K | -312.22%-686.93K | -8.01%-1.92M | 9.29%-538.54K | 15.95%-453.92K | -226.21%-759.66K | 59.34%-166.64K |
| Net income from continuing operations | -258.80%-9.08M | -846.49%-7.91M | 57.91%-252.38K | 71.23%-246.82K | -183.95%-677.27K | -33.48%-2.53M | -58.78%-835.39K | -11.47%-599.65K | -56.70%-858.05K | 16.31%-238.52K |
| Operating gains losses | 63.82%-35.95K | ---5.9K | ---- | ---- | ---- | ---99.34K | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 137.22%2.12K | -24.54%529 | 176.96%529 | --529 | --529 | --892 | --701 | --191 | --0 | --0 |
| Asset impairment expenditure | --6.88M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Remuneration paid in stock | -74.05%60.24K | --0 | --0 | 0.58%23.84K | -27.70%36.4K | 233.80%232.08K | -2.94%67.48K | --90.55K | --23.7K | --50.35K |
| Other non cashItems | --8.66K | --1.75K | --3.75K | ---250 | --3.41K | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | 75.15%839.37K | 157.50%844.66K | -66.56%18.39K | -64.77%26.31K | -332.19%-49.99K | 844.45%479.23K | 339.32%328.02K | 2,732.46%54.99K | -76.26%74.69K | 117.25%21.53K |
| -Change in receivables | -62.83%-70.17K | -48.62%-11.18K | -223.58%-36.84K | 60.12%-7.32K | -154.25%-14.83K | 18.26%-43.09K | 32.84%-7.52K | 2.44%-11.39K | -86.50%-18.35K | 70.85%-5.83K |
| -Change in prepaid assets | 90.98%-1.52K | -8.35%13.73K | 418.51%19.16K | 100.31%55 | -91.48%-34.47K | 7.50%-16.83K | 183.72%14.99K | 1,344.11%3.7K | ---17.51K | ---18K |
| -Change in payables and accrued expense | 68.98%911.05K | 162.70%842.11K | -42.46%36.07K | -69.63%33.58K | -101.54%-699 | 343.19%539.16K | 396.92%320.56K | 534.56%62.68K | -65.93%110.56K | 143.29%45.36K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 30.70%-1.33M | 65.36%-186.53K | 42.77%-259.76K | 74.15%-196.39K | -312.22%-686.93K | -8.01%-1.92M | 9.29%-538.54K | 15.95%-453.91K | -226.21%-759.66K | 59.34%-166.64K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 9.66%-329.06K | -2,558.02%-329.06K | 0 | 0 | 0 | -364.25K | -106.26%-12.38K | -7.78K | -344.09K | 0 |
| Net PPE purchase and sale | 9.66%-329.06K | -2,558.02%-329.06K | --0 | --0 | --0 | ---364.25K | -106.26%-12.38K | ---7.78K | ---344.09K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 9.66%-329.06K | -2,558.02%-329.06K | --0 | --0 | --0 | ---364.25K | -106.26%-12.38K | ---7.78K | ---344.09K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -29.59%1.51M | -32.14%340.63K | 38,442.61%420.24K | -97.88%34.97K | 716.61K | 2.15M | 501.94K | -1.1K | 1.65M | 0 |
| Net issuance payments of debt | -141.67%-50K | --0 | --0 | --0 | ---50K | --120K | --120K | --0 | --0 | --0 |
| Net common stock issuance | -10.19%1.56M | 131.56%343.6K | 1,320.27%420.24K | -98.03%32K | --766.61K | --1.74M | --148.38K | ---34.44K | --1.63M | --0 |
| Proceeds from stock option exercised by employees | --0 | 85.56%-2.97K | --0 | ---- | ---- | --0 | ---20.54K | ---1.1K | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | ---- | --2.97K | --288.54K | --254.1K | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -29.59%1.51M | -32.14%340.63K | 38,442.61%420.24K | -98.06%32K | --719.57K | --2.15M | --501.94K | ---1.1K | --1.65M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -45.87%159.07K | -9.73%187.8K | -95.93%27.32K | 50.68%191.71K | -45.87%159.07K | -85.81%293.87K | -69.84%208.04K | -45.46%670.83K | -92.34%127.23K | -85.81%293.87K |
| Current changes in cash | -8.48%-146.23K | -257.25%-174.96K | 134.68%160.47K | -130.24%-164.39K | 119.59%32.65K | 92.41%-134.8K | 87.63%-48.97K | 14.31%-462.79K | 226.26%543.6K | 59.34%-166.64K |
| End cash Position | -91.93%12.84K | -91.93%12.84K | -9.73%187.8K | -95.93%27.32K | 50.68%191.71K | -45.87%159.07K | -45.87%159.07K | -69.84%208.04K | -45.46%670.83K | -92.34%127.23K |
| Free cash from | 27.35%-1.66M | 6.41%-515.59K | 43.74%-259.76K | 82.21%-196.39K | -312.22%-686.93K | -28.52%-2.28M | -39.12%-550.92K | 14.51%-461.69K | -156.37%-1.1M | 59.34%-166.64K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.